Shameer Pillarisetti

Targeted immunomodulation with CD44-targeting nanovaccine enhances antitumor immunity in melanoma through TLR7/8 and TLR3 agonists.

Cancer is a leading cause of death. Melanoma, a highly metastatic and aggressive skin cancer, has seen rising mortality rates despite advancements in chemotherapy. Recently, immunotherapy has emerged as a promising approach to address the limitations of conventional treatments. This study developed a tumor microenviron...